Medicare drug coverage

Forteo: 2027 Medicare Part D coverage

1,033 of 5,495 Part D plans (19%) list Forteo on their 2027 formulary, the plan's list of covered drugs (down 2 points from 2026). 89% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (5,172 MA-PD) and stand-alone drug plans (323 PDP).

License: a US government work, in the public domain (Public Domain Mark 1.0).

Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.

For pharmacies and agencies: check a whole drug list against 2027 formularies.

Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.

2027 compared with 2026

Forteo is number 153 by total Medicare Part D spending in 2024 ($266 million). Plans that list it most often put it on tier 5 (a tier is the cost level a plan puts a drug on; a lower tier usually costs less). Counts use 2 RxNorm products for this name.

Forteo Part D coverage, 2026 and 2027
Measure20262027Change
Part D plans in the file5,5185,495-23
Plans that list it1,161 (21%)1,033 (19%)-2 points
Prior authorization (of plans that list it)1,046 (90%)921 (89%)-1 point
Step therapy (of plans that list it)0 (0%)0 (0%)no change
Quantity limit (of plans that list it)947 (82%)921 (89%)+7 points
Any of the three (of plans that list it)1,046 (90%)921 (89%)-1 point
Not listed or restricted (of all plans)5,403 (98%)5,383 (98%)no change

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Every 2027 stand-alone drug plan

Each stand-alone Part D plan (PDP) with Forteo's 2027 tier and limits. CMS files a PDP once per region, so one plan name can have several plan IDs; the row shows the tier and limits most of them use. Medicare Advantage drug plans are local: pick a state for its plan-by-plan table.

Forteo on every 2027 stand-alone Part D plan
Plan (PDP)Plan IDs2027 tier2027 limits
AARP Medicare Rx Preferred from UHC (PDP)39Not listedNot listed
AARP Medicare Rx Saver from UHC (PDP)34Not listedNot listed
Blue Medicare Rx Enhanced (PDP)1Not listedNot listed
Blue Medicare Rx Standard (PDP)1Not listedNot listed
Blue MedicareRx Essentials (PDP)1Not listedNot listed
Blue MedicareRx Plus (PDP)1Not listedNot listed
Blue MedicareRx Premier (PDP)1Not listedNot listed
Blue MedicareRx Value (PDP)1Not listedNot listed
Blue MedicareRx Value Plus (PDP)1Not listedNot listed
Blue Shield Rx Enhanced (PDP)1Not listedNot listed
Blue Shield Rx Plus (PDP)1Not listedNot listed
BlueMedicare Complete Rx (PDP)1Not listedNot listed
BlueMedicare Premier Rx (PDP)2Not listedNot listed
BlueMedicare Value Rx (PDP)1Not listedNot listed
BlueRx Enhanced Plus (PDP)1Not listedNot listed
BlueRx Essential (PDP)1Not listedNot listed
HealthSpring Assurance Rx (PDP)35Not listedNot listed
HealthSpring Extra Rx (PDP)2Not listedNot listed
HealthSpring Extra RX (PDP)3Not listedNot listed
Horizon Medicare Blue Rx Enhanced (PDP)1Not listedNot listed
Horizon Medicare Blue Rx Standard (PDP)1Not listedNot listed
Humana Basic Rx Plan (PDP)34Tier 5PA, QL
Humana Premier Rx Plan (PDP)34Tier 5PA, QL
Humana Value Rx Plan (PDP)34Tier 5PA, QL
MedicareBlue Rx Standard (PDP)1Not listedNot listed
Prescription Blue Premium (PDP)1Not listedNot listed
Prescription Blue Select (PDP)1Not listedNot listed
SilverScript Choice (PDP)20Not listedNot listed
Wellcare Classic (PDP)34Not listedNot listed
Wellcare Value Script (PDP)34Not listedNot listed

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Formulary tier

Forteo formulary tier, 2026 and 2027
Tier2026 plans2027 plans
Tier 132 (3%)9 (1%)
Tier 3115 (10%)112 (11%)
Tier 51,014 (87%)912 (88%)

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Plan by plan, 2026 to 2027

4,380 plan IDs are in both files. 0 of them (0%) added prior authorization, step therapy, or a quantity limit for Forteo, and 69 stopped listing it.

Forteo: plans in both 2026 and 2027
Plan by planPlans
Same plan ID in both years4,380
Listed it in 2026, not in 202769 (2%)
Listed it in 2027, not in 20260 (0%)
Moved it to a higher tier0 (0%)
Added prior authorization0 (0%)
Added step therapy0 (0%)
Added a quantity limit0 (0%)
Added at least one of the three0 (0%)
Removed at least one of the three1 (<1%)
Plan IDs new in 20271,115
2026 plan IDs not in the 2027 file1,138

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

States from most to least restrictive

Share of 2027 Part D plans offered in each state that leave Forteo off the formulary or list it with prior authorization, step therapy, or a quantity limit. 41 states tie for the highest share, 100%; Maryland ranks last at 80%. States at the same share are ordered by the prior authorization or step therapy share; states equal on both shares share a rank, marked Tied.

States from most to least restrictive for Forteo, 2027
RankState2027 plansNot listed or restrictedPrior auth or step therapyChange from 2026
1Montana27100%63%no change
2Vermont14100%50%no change
3Wyoming13100%38%no change
4New Hampshire25100%36%no change
5Kentucky123100%35%no change
6Alaska9100%33%no change
Tied 7Louisiana126100%29%no change
Tied 7Maine52100%29%no change
Tied 9Oklahoma81100%28%no change
Tied 9Utah53100%28%no change
Tied 11South Carolina91100%26%no change
Tied 11West Virginia70100%26%no change
Tied 11Arkansas86100%26%no change
Tied 14Idaho45100%24%no change
Tied 14Mississippi105100%24%no change
16Kansas84100%23%no change
Tied 17Indiana140100%22%no change
Tied 17Illinois133100%22%no change
Tied 19Florida549100%21%no change
Tied 19Wisconsin97100%21%no change
Tied 19New Mexico68100%21%no change
22Missouri171100%20%no change
23New Jersey74100%19%no change
Tied 24Alabama115100%17%no change
Tied 24Texas412100%17%no change
Tied 24North Carolina177100%17%no change
Tied 27Delaware43100%16%no change
Tied 27Nebraska51100%16%no change
Tied 27Arizona148100%16%no change
Tied 30Massachusetts92100%14%no change
Tied 30Iowa64100%14%no change
Tied 30Tennessee157100%14%no change
Tied 33Ohio173100%13%no change
Tied 33Connecticut54100%13%no change
Tied 35Pennsylvania324100%12%no change
Tied 35North Dakota26100%12%no change
Tied 37Rhode Island29100%10%no change
Tied 37South Dakota30100%10%no change
Tied 37Michigan183100%10%no change
Tied 40Minnesota63100%5%no change
Tied 40New York215100%5%no change
42Nevada10097%19%-3 points
43Virginia14596%31%no change
44Oregon9296%14%no change
45Georgia15195%24%no change
46Colorado10690%18%+3 points
47Hawaii5088%16%no change
48California39788%8%no change
49District of Columbia2186%19%-2 points
50Washington11486%17%+1 point
51Maryland4980%14%-4 points

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

By parent organization

164 parent organizations offer 2027 Part D plans. Humana Inc. has the most, 884, and 100% of them leave Forteo off or restrict it.

Forteo coverage by parent organization, 2027
Parent organization2027 plans ↑List itRestrict it (of listing)Not listed or restrictedChange from 2026Plans that added a restriction
CoxHealth30%none list it100%no change0
First Sacramento Capital Funding LLC30%none list it100%no change0
Imperial Health Plan of California30%none list it100%no change0
Liberty Healthcare Insurance30%none list it100%no change0
Marquis Companies I, Inc.30%none list it100%no change0
McLaren Health Care Corporation30%none list it100%no change0
MedCare Partners Holding, LLC30%none list it100%new in 20270
Mercy Care30%none list it100%no change0
New York City Health and Hospitals Corporation30%none list it100%no change0
Presbyterian Healthcare Services30%none list it100%no change0
SIHO Holding, Inc.30%none list it100%no change0
St. Luke's Health System, Inc.30%none list it100%new in 20270
VISITING NURSE ASSOCIATION OF CENTRAL NEW YORK30%none list it100%no change0
Village Care of New York, Inc.30%none list it100%no change0
Visiting Nurse Service of New York30%none list it100%no change0
Chapters CareNu Inc40%none list it100%no change0
Chinese Hospital Association40%none list it100%no change0
El Paso County Hospital District40%none list it100%no change0
Elderplan, Inc.40%none list it100%no change0
Horizon Mutual Holdings, Inc40%none list it100%no change0
LMC Family Holdings, LLC40%none list it100%no change0
Montage Health40%none list it100%no change0
St Francis Health System & St John Health System40%none list it100%no change0
Blue Cross & Blue Shield of Rhode Island50%none list it100%no change0
BlueCross BlueShield of Alabama50%none list it100%no change0

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Other Teriparatide products

Near it by Part D spending

About this data

A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.

A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.